Search results

1. Assessment of the potential development of novel antibody fragments targeting IL13Rα2 using the phage display technique …

Principal investigator: dr Justyna Katarzyna Jureczek

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: PRELUDIUM 22, Panel: NZ5

2. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t…

Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 20, Panel: NZ7

3. The first antibody-drug conjugates for Alzheimer's disease therapy

Principal investigator: dr hab. Marcin Łukasz Poręba

Politechnika Wrocławska

Call: SONATA BIS 14, Panel: NZ5

4. Antibodies and microbiota as tools for asthma prevention

Principal investigator: dr hab. Tomasz Piotr Wypych

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 26 (LAP), Panel: NZ6

5. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for …

Principal investigator: dr hab. Monika Bzowska

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

Call: OPUS 25, Panel: NZ6

6. The quantity and functional state of γδT lymphocytes in adult patients with primary immunodeficiencies (PIDs) especially…

Principal investigator: prof. Jacek Mariusz Roliński

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM BIS 3, Panel: NZ6

7. Heterogenous diamond biosensing nanoarchitectures: opto-electro-chemical interactions with antibody complexes

Principal investigator: dr hab. Robert Daniel Bogdanowicz

Politechnika Gdańska

Call: OPUS 22 (LAP), Panel: ST7

8. Analysis of antibodies orientation on biosensing surfaces modifed with molecular and macromolecular layers using seconda…

Principal investigator: dr Katarzyna Gajos

Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

Call: SONATA 17, Panel: ST5

9. Mechanisms of immunity directed against coronaviruses based on theanalysis of antibodies in convalescents, exposed/sub-c…

Principal investigator: prof. Piotr Bogumił Heczko

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 20, Panel: NZ6

10. Dissecting cancer activome to develop new generation of antibody-drug conjugates

Principal investigator: dr hab. Marcin Łukasz Poręba

Politechnika Wrocławska

Call: OPUS 20 (LAP), Panel: NZ5

11. Improving therapeutic efficacy of anti-CD20 antibodies in precursor B-cell acute lymphoblastic leukemia

Principal investigator: dr Małgorzata Firczuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 18, Panel: NZ5

12. Concept of the universal antibody targeting tumor cells resistant to first-line immunotherapeutics.

Principal investigator: dr hab. Marcin Sebastian Okrój

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Call: OPUS 18, Panel: NZ6

13. Liposomal berberine and anti-CD47 antibody as an effective therapy for the treatment of colorectal cancer

Principal investigator: dr Martyna Maria Mianowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: PRELUDIUM 17, Panel: NZ5

14. Crystallization of monoclonal antibodies by forced convection evaporation

Principal investigator: Michał Kołodziej

Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

Call: PRELUDIUM 16, Panel: ST8

15. Antibody-redox active molecule conjugates as platform for simultaneous electrochemical determination of low density lipo…

Principal investigator: dr hab. Iwona Ewa Grabowska

Instytut Rozrodu Zwierząt i Badań Żywności PAN

Call: OPUS 13, Panel: ST4

16. NK cells with inducible expression of CAR as novel immunotherapy increasing the efficacy of monoclonal antibodies.

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 12, Panel: NZ5

17. Anti-citrullinated chemokine antibodies in pathofisiology, diagnostics and prognosis of rheumatoid arthritis

Principal investigator: dr Oleksandr Korchynskyy

Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

Call: OPUS 12, Panel: NZ5

18. Silicon biosensing surfaces functionalized with many molecules: direct analysis of antibody orientation and antigens bin…

Principal investigator: Katarzyna Gajos

Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

Call: PRELUDIUM 11, Panel: ST5

19. Endocytosis-stimulating antibodies against multidrug transporters as drug carriers

Principal investigator: dr hab. Łukasz Pułaski

Instytut Biologii Medycznej PAN

Call: OPUS 10, Panel: NZ7

20. Clinical, biochemical and genetic factros for response to antibody anti-IgE treatment in asthma phenotypes

Principal investigator: prof. Lucyna Maria Mastalerz

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 10, Panel: NZ5

21. Identification of novel therapies potentiating the efficacy of immunotherapy with anti-CD20 antibodies in in vivo models…

Principal investigator: dr Magdalena Winiarska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA BIS 5, Panel: NZ6

22. Influence of the hinge region of mouse IgG3 antibodies on their unique features and functions.

Principal investigator: Tomasz Jakub Klaus

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: PRELUDIUM 9, Panel: NZ1

23. The physical properties of complexes of antibodies from the lipopolisaccharide form S and R strains of Proteus mirabilis…

Principal investigator: Joanna Maria Gleńska-Olender

Uniwersytet Jana Kochanowskiego w Kielcach, Wydział Matematyczno-Przyrodniczy

Call: PRELUDIUM 8, Panel: NZ6

24. New protein bilayer system based on antigen-antibody interactions - is situ physicochemical characteristics

Principal investigator: dr Monika Wasilewska

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: SONATA 7, Panel: ST4

25. Three dimensional distribution of antinuclear antibodies in various autoimmunological disorders.

Principal investigator: dr Krzysztof Wójcik

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: PRELUDIUM 6, Panel: NZ6

26. Characterization of immunogenic proteins of Streptococcus agalactiae and the identification of the epitope recognized by…

Principal investigator: dr hab. Monika Brzychczy-Włoch

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 5, Panel: NZ6

27. Molecular mechanisms of cell death evoked by a monoclonal antibody binding to GD2 ganglioside expressed on human neurobl…

Principal investigator: prof. Hanna Barbara Rokita

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 4, Panel: NZ1

28. Influence of the B cell receptor (BCR) signaling pathways on CD20 levels in tumor cells and antitumor activity of anti-C…

Principal investigator: dr Magdalena Winiarska

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Call: OPUS 4, Panel: NZ6

29. Monoclonal recombinant antibodies for the characterisation of important parasite molecules.

Principal investigator: dr Luke James Norbury

Instytut Parazytologii im. Witolda Stefańskiego PAN

Call: OPUS 3, Panel: NZ6

30. Cytotoxic conjugates targeting FGFR-related cancers based on FGF1 and FGFR-specific antibodies.

Principal investigator: prof. Jacek Józef Otlewski

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: MAESTRO 1, Panel: NZ1

31. Interactions of human cystatin C with antibodies as an effective method of fighting Icelandic type hereditary cerebral h…

Principal investigator: Izabela Sylwia Behrendt

Uniwersytet Gdański, Wydział Chemii

Call: PRELUDIUM 1, Panel: ST5

32. Evaluation of protective level of antibodies to diphtheria toxin in selected groups of Polish population

Principal investigator: dr Aleksandra Anna Zasada

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: OPUS 1, Panel: NZ7

33. Characteristics of anti-lipid IgG antibodies in patients with relapsing-remitting multiple sclerosis: physico-chemical p…

Principal investigator: Anna Izabela Jakubiak-Augustyn

Uniwersytet Wrocławski

Call: PRELUDIUM 23, Panel: NZ3

34. Novel monovalent and multivalent recombinant proteins of Borrelia burgdorferi sensu lato as potential antigens for the d…

Principal investigator: dr hab. Lucyna Holec-Gąsior

Politechnika Gdańska, Wydział Chemiczny

Call: OPUS 25, Panel: NZ6

35. GENETIC AND EPIGENETIC BACKGROUND OF ANTIBODY PRODUCTION DEFECTS IN CHILDREN– IN SEARCH OF A PATHOPHYSIOLOGICAL MODEL OF…

Principal investigator: dr hab. Aleksandra Anna Szczawińska-Popłonyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 24, Panel: NZ6

36. The specificity and cross-reactivity anti- Proteus mirabilis LPS antibodies isolated from the sera of patients with rheu…

Principal investigator: Katarzyna Sylwia Durlik-Popińska

Uniwersytet Jana Kochanowskiego w Kielcach, Wydział Nauk Ścisłych i Przyrodniczych; Instytut Biologii

Call: PRELUDIUM 16, Panel: NZ6

37. Function of autophagy in neuroblastoma cell death evoked by GD2 ganglioside-recognizing monoclonal antibodies.

Principal investigator: dr Małgorzata Aleksandra Durbas

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: PRELUDIUM 10, Panel: NZ1

38. In vitro and in vivo preclinical studies of NaA nanozeolite functionalized with antibodies anti-PSMA and labeled with ra…

Principal investigator: prof. Anna Małgorzata Lankoff

Instytut Chemii i Techniki Jądrowej

Call: OPUS 10, Panel: NZ7

39. Nanoparticle conjugates with the monoclonal antibody - a new opening in target tumor therapy

Principal investigator: Monika Anna Marcinkowska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 10, Panel: NZ3

40. Influence of AKT signaling pathway on CD20 expression and antitumor activity of therapeutic monoclonal antibodies.

Principal investigator: dr Beata Pyrzyńska

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Call: OPUS 6, Panel: NZ5

41. TRAP protein cage as an easily modifiable platform for biomedical purposes

Principal investigator: Szymon Kazimierz Gaweł

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: PRELUDIUM 20, Panel: NZ1

42. Trichinella spiralis and Trichinella britovi multi-antigen vaccine - a new approach to prevent trichinellosis

Principal investigator: dr Anna Beata Stachyra

Warszawski Uniwersytet Medyczny

Call: SONATA 20, Panel: NZ6

43. Decoding novel O/K loci of Klebsiella pneumoniae into chemical O/K antigen structures – towards better adjustment of bac…

Principal investigator: prof. Jolanta Katarzyna Łukasiewicz

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: OPUS 27, Panel: NZ7

44. Evolution of Major Histocompatibility Complex (MHC) genes and pathogen antigens, induced by adaptive immune response and…

Principal investigator: dr Maciej Jan Ejsmond

Uniwersytet Jagielloński

Call: OPUS 27, Panel: NZ8

45. Longitudinal analysis of changes in the expression, activity, and regulation mechanisms of the NLRP3 inflammasome in mon…

Principal investigator: prof. Joanna Saluk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

46. Searching for novel regulators of antitumor immune response

Principal investigator: dr hab. Magdalena Hanna Winiarska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: MAESTRO 15, Panel: NZ6

47. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

Principal investigator: dr hab. Magdalena Stobiecka

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Call: OPUS 25, Panel: ST4

48. Heme acquisition mechanisms of oral anaerobic Bacteroidetes members: from structure-function studies to development of b…

Principal investigator: prof. Teresa Barbara Olczak

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 25, Panel: NZ6

49. Depletion of the tumor microenvironment as a novel strategy potentiating the efficacy of immunotherapies.

Principal investigator: dr Małgorzata Agnieszka Bajor

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 23, Panel: NZ6

50. Bionanoparticles with a molecular targeting device as a weapon for breast cancer

Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 23, Panel: NZ7

Projects search